Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics
This paper explored the novel approach of targeting the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway for the treatment of osteosarcoma (OS). Osteosarcoma is a common malignancy in adolescents. Most patients die from l...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539396/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825206693483511808 |
|---|---|
| author | BingBing Li Cheng Zhang XiaoJuan Xu QiQin Shen ShuNan Luo JunFeng Hu |
| author_facet | BingBing Li Cheng Zhang XiaoJuan Xu QiQin Shen ShuNan Luo JunFeng Hu |
| author_sort | BingBing Li |
| collection | DOAJ |
| description | This paper explored the novel approach of targeting the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway for the treatment of osteosarcoma (OS). Osteosarcoma is a common malignancy in adolescents. Most patients die from lung metastasis. It reviewed the epidemiology and pathological characteristics of OS, highlighting its highly malignant nature and tendency for pulmonary metastasis, underscoring the importance of identifying new therapeutic targets. The cGAS-STING pathway was closely associated with the malignant biological behaviors of OS cells, suggesting that targeting this pathway could be a promising therapeutic strategy. Currently, research on the role of the cGAS-STING pathway in OS treatment has been limited, and the underlying mechanisms remain unclear. Therefore, further investigation into the mechanisms of the cGAS-STING pathway in OS and the exploration of therapeutic strategies based on this pathway are of great significance for developing more effective treatments for OS. This paper offered a fresh perspective on the treatment of OS, providing hope for new therapeutic options for OS patients by targeting the cGAS-STING pathway. |
| format | Article |
| id | doaj-art-1ce3eb63a928490799be0e89d0609690 |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-1ce3eb63a928490799be0e89d06096902025-02-07T06:49:40ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15393961539396Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeuticsBingBing Li0Cheng Zhang1XiaoJuan Xu2QiQin Shen3ShuNan Luo4JunFeng Hu5Department of Pediatrics, Shaoxing Central Hospital, The Central Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Pediatrics, Shaoxing Central Hospital, The Central Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Pediatrics, Shaoxing Central Hospital, The Central Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Orthopedics, Shaoxing Central Hospital, The Central Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Surgery, Shaoxing People’s Hospital, Shaoxing, Zhejiang, ChinaDepartment of Pain, Shaoxing People’s Hospital, Shaoxing, Zhejiang, ChinaThis paper explored the novel approach of targeting the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway for the treatment of osteosarcoma (OS). Osteosarcoma is a common malignancy in adolescents. Most patients die from lung metastasis. It reviewed the epidemiology and pathological characteristics of OS, highlighting its highly malignant nature and tendency for pulmonary metastasis, underscoring the importance of identifying new therapeutic targets. The cGAS-STING pathway was closely associated with the malignant biological behaviors of OS cells, suggesting that targeting this pathway could be a promising therapeutic strategy. Currently, research on the role of the cGAS-STING pathway in OS treatment has been limited, and the underlying mechanisms remain unclear. Therefore, further investigation into the mechanisms of the cGAS-STING pathway in OS and the exploration of therapeutic strategies based on this pathway are of great significance for developing more effective treatments for OS. This paper offered a fresh perspective on the treatment of OS, providing hope for new therapeutic options for OS patients by targeting the cGAS-STING pathway.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539396/fullosteosarcomacGAS-STINGtreatment targetdrugtumor immunity |
| spellingShingle | BingBing Li Cheng Zhang XiaoJuan Xu QiQin Shen ShuNan Luo JunFeng Hu Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics Frontiers in Immunology osteosarcoma cGAS-STING treatment target drug tumor immunity |
| title | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics |
| title_full | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics |
| title_fullStr | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics |
| title_full_unstemmed | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics |
| title_short | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics |
| title_sort | manipulating the cgas sting axis advancing innovative strategies for osteosarcoma therapeutics |
| topic | osteosarcoma cGAS-STING treatment target drug tumor immunity |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539396/full |
| work_keys_str_mv | AT bingbingli manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics AT chengzhang manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics AT xiaojuanxu manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics AT qiqinshen manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics AT shunanluo manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics AT junfenghu manipulatingthecgasstingaxisadvancinginnovativestrategiesforosteosarcomatherapeutics |